In this comment letter to the Securities and Exchange Commission, we underscore that the SEC has established statutory authority authorizing its ability to require disclosures regarding climate risks that face companies, and that there is overwhelming evidence that such information is important...

The high prevalence of chronic diseases in the United States with lifestyle-related risk factors, such as obesity and tobacco use, has sparked interest in legal strategies to influence health behavior. However, little is known about the public's willingness to accept these policies as...

Under “disclosure-and-resolution” programs, health systems disclose adverse events to affected patients and their families; apologize; and, where appropriate, offer compensation. Early adopters of this approach have reported reduced liability costs, but the extent to which these results stem...

This paper introduces a special issue of the Journal of Health Policy, Politics & Law focusing on public health law legal research (PHLR). PHLR is the "scientific study of the relation of law and legal practices to population health." A relatively new and burgeoning interdisciplinary field, PHLR...

Medical process patents, which protect intellectual property in medical and surgical procedures, threaten to complicate medical practice, increase health care costs, and restrict access to therapeutic and diagnostic modalities. Few countries allow such patents, but they have been granted in the...

The notion that the tort liability system deters negligence in health care has been invoked to make the "business case for patient safety." However, existing data on the relationship between hospital adverse events and malpractice claims typically are interpreted as evidence that the tort system...